Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

298 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Completed

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

NCT01982448

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Indiana University- Simon Cancer Center Indianapolis, Indiana, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Completed

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

NCT06273852

Conditions
Breast Diseases, Breast Neoplasms, Carcinoma, +13 more
Locations
  • LSU Health Sciences Center Shreveport, Louisiana, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Sarah Cannon Research Institute Charleston, South Carolina, United States
View Trial Details
Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

NCT04580485

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +59 more
Locations
  • Cedars-Sinai Medical Center West Hollywood, California, United States
  • University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 27 locations
View Trial Details
Completed

A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands

NCT01351103

Conditions
BRAF Mutant Colorectal Cancer, Breast Diseases, Breast Neoplasms, +35 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Baltimore, Maryland, United States
  • Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Onc Dept. Ann Arbor, Michigan, United States
View all 20 locations
View Trial Details
Completed

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT05253053

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Cancer, +56 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Completed

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

NCT02632448

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +55 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View all 16 locations
View Trial Details

Related conditions